Cargando…

BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction

Promyelocytic leukemia protein (PML) modulates the p53 tumor suppressor through its interaction with p53 and MDM2. We found that activated BMK1 preferentially associates with PML isoform IV and disrupts PML-MDM2 interaction. Doxorubicin, a common chemotherapeutic agent, is known to promote PML-media...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Q, Liao, L, Deng, X, Chen, R, Gray, N S., Yates, J R., Lee, JD
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493705/ https://www.ncbi.nlm.nih.gov/pubmed/22869143 http://dx.doi.org/10.1038/onc.2012.332

Ejemplares similares

Mad1 destabilizes p53 by preventing PML from sequestering MDM2
por: Wan, Jun, et al.
Publicado: (2019)

EGCG binds intrinsically disordered N-terminal domain of p53 and disrupts p53-MDM2 interaction
por: Zhao, Jing, et al.
Publicado: (2021)

Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction
por: Thayer, Kelly M., et al.
Publicado: (2016)

Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma
por: Song, Chengli, et al.
Publicado: (2017)

Structure-based designing efficient peptides based on p53 binding site residues to disrupt p53-MDM2/X interaction
por: Rasafar, Nasim, et al.
Publicado: (2020)

The Dual Interactions of p53 with MDM2 and p300: Implications for the Design of MDM2 Inhibitors
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2019)

Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma
por: Song, Chengli, et al.
Publicado: (2017)

The p53–Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans
por: Coffill, Cynthia R., et al.
Publicado: (2016)

Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent pathway
por: Kundu, Nandini, et al.
Publicado: (2017)

Targeting the p53–MDM2 interaction to treat cancer
por: Klein, C, et al.
Publicado: (2004)

Explaining oscillations and variability in the p53-Mdm2 system
por: Proctor, Carole J, et al.
Publicado: (2008)

Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis
por: Liu, Shijie, et al.
Publicado: (2016)

Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor
por: Tian, X X, et al.
Publicado: (1999)

BmK-YA, an Enkephalin-Like Peptide in Scorpion Venom
por: Zhang, Yan, et al.
Publicado: (2012)

8-Triazolylpurines: Towards Fluorescent Inhibitors of the MDM2/p53 Interaction
por: Pettersson, Mariell, et al.
Publicado: (2015)

Disruption of the MDM2–p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway
por: Koster, R, et al.
Publicado: (2011)

Circular RNA CDR1as disrupts the p53/MDM2 complex to inhibit Gliomagenesis
por: Lou, Jiacheng, et al.
Publicado: (2020)

Simultaneous measurement of p53:Mdm2 and p53:Mdm4 protein-protein interactions in whole cells using fluorescence labelled foci
por: Frosi, Y., et al.
Publicado: (2019)

ODP281 JDP2 Interacts with MDM2 and Decreases MDM2-Mediated p53 Repression
por: Yang, William, et al.
Publicado: (2022)

On the Mechanism of Action of SJ-172550 in Inhibiting the Interaction of MDM4 and p53
por: Bista, Michal, et al.
Publicado: (2012)

NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2
por: Liu, Xiaofeng, et al.
Publicado: (2016)

Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
por: Grinkevich, Vera V., et al.
Publicado: (2022)

Diaryl- and triaryl-pyrrole derivatives: inhibitors of the MDM2–p53 and MDMX–p53 protein–protein interactions
por: Blackburn, Tim J., et al.
Publicado: (2013)

Regulation of p53: a collaboration between Mdm2 and MdmX
por: Pei, Dongsheng, et al.
Publicado: (2012)

Regulation of kidney development by the Mdm2/Mdm4–p53 axis
por: El-Dahr, Samir, et al.
Publicado: (2017)

Bmk-1 regulates lifespan in Caenorhabditis elegans by activating hsp-16
por: Qian, Hong, et al.
Publicado: (2015)

Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
por: Mrkvová, Zuzana, et al.
Publicado: (2019)

Regulating the p53 Tumor Suppressor Network at PML Biomolecular Condensates
por: Liebl, Magdalena C., et al.
Publicado: (2022)

Mdm2 RING Mutation Enhances p53 Transcriptional Activity and p53-p300 Interaction
por: Clegg, Hilary V., et al.
Publicado: (2012)

MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation
por: Qi, Dong-Lai, et al.
Publicado: (2016)

Detection of P53 and Mdm2 in vitiligo
por: Wiwanitkit, Viroj
Publicado: (2013)

The MDM2-p53 pathway revisited
por: Nag, Subhasree, et al.
Publicado: (2013)

Evolution of the p53-MDM2 pathway
por: Åberg, Emma, et al.
Publicado: (2017)

The MDM2-p53 pathway is involved in preconditioning-induced neuronal tolerance to ischemia
por: Vecino, Rebeca, et al.
Publicado: (2018)

PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells
por: Davies, L, et al.
Publicado: (2011)

mRNA Display Selection of an Optimized MDM2-Binding Peptide That Potently Inhibits MDM2-p53 Interaction
por: Shiheido, Hirokazu, et al.
Publicado: (2011)

Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
por: Zhu, Haohao, et al.
Publicado: (2022)

PKA phosphorylation reshapes the pharmacological kinetics of BmK AS, a unique site-4 sodium channel-specific modulator
por: Liu, Z. R., et al.
Publicado: (2014)

Functionalized Double Strain-Promoted Stapled Peptides for Inhibiting the p53-MDM2 Interaction
por: Sharma, Krishna, et al.
Publicado: (2020)

Protoporphyrin IX is a dual inhibitor of p53/MDM2 and p53/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells
por: Jiang, Liren, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uvakharccco244qnaf439g7tk9